Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study.
Baxter SM, Lund LC, Andersen JH, Brix TH, Hegedüs L, Hsieh MH, Su CT, Cheng MC, Chang ZC, Lai EC, Hussain S, Chu C, Gomes T, Antoniou T, Eskander A, Bouck Z, Tadrous M, Bea S, Choi EY, Shin JY, Modig K, Talbäck M, Ljung R, Gulseth HL, Karlstad Ø, Hicks B, Pottegård A. Baxter SM, et al. Among authors: su ct. Thyroid. 2025 Jan 8. doi: 10.1089/thy.2024.0387. Online ahead of print. Thyroid. 2025. PMID: 39772758
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial.
Platt HL, Bruno C, Buntinx E, Pelayo E, Garcia-Huidobro D, Barranco-Santana EA, Sjoberg F, Song JY, Grijalva CG, Orenstein WA, Morgan L, Fernsler D, Xu W, Waleed M, Li J, Buchwald UK; STRIDE-3 Study Group. Platt HL, et al. Lancet Infect Dis. 2024 Oct;24(10):1141-1150. doi: 10.1016/S1473-3099(24)00344-X. Epub 2024 Jul 1. Lancet Infect Dis. 2024. PMID: 38964361 Clinical Trial.
Developing an entrustable professional activity for providing health education and consultation in occupational therapy and examining its validity.
Fu CP, Huang CK, Yang YC, Liao WS, Huang SM, Chang WD, Chen YJ, Li MW, Lin YJ, Wu CL, Chi HY, Lee CY, Chiang FM, Chen YL, Tsou CF, Liu TH, Su CT, Yang AL, Kuo NC, Chang WY. Fu CP, et al. Among authors: su ct. BMC Med Educ. 2024 Jun 28;24(1):705. doi: 10.1186/s12909-024-05670-1. BMC Med Educ. 2024. PMID: 38943116 Free PMC article.
Mitigating time toxicity in lymphoma and multiple myeloma.
Di M, Su CT, Cowan AJ, Gopal AK, Banerjee R. Di M, et al. Among authors: su ct. Leuk Lymphoma. 2024 Oct;65(10):1418-1429. doi: 10.1080/10428194.2024.2352086. Epub 2024 May 15. Leuk Lymphoma. 2024. PMID: 38749027 Review.
Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer.
Mishra AK, Ye T, Banday S, Thakare RP, Su CT, Pham NNH, Ali A, Kulshreshtha A, Chowdhury SR, Simone TM, Hu K, Zhu LJ, Eisenhaber B, Deibler SK, Simin K, Thompson PR, Kelliher MA, Eisenhaber F, Malonia SK, Green MR. Mishra AK, et al. Among authors: su ct. Cell Rep. 2024 Apr 23;43(4):114041. doi: 10.1016/j.celrep.2024.114041. Epub 2024 Apr 3. Cell Rep. 2024. PMID: 38573857 Free article.
380 results